WO2008133464A1 - Biopuce pour quantifier des acides aminés et procédé pour analyser des acides aminés au moyen de ladite biopuce - Google Patents

Biopuce pour quantifier des acides aminés et procédé pour analyser des acides aminés au moyen de ladite biopuce Download PDF

Info

Publication number
WO2008133464A1
WO2008133464A1 PCT/KR2008/002395 KR2008002395W WO2008133464A1 WO 2008133464 A1 WO2008133464 A1 WO 2008133464A1 KR 2008002395 W KR2008002395 W KR 2008002395W WO 2008133464 A1 WO2008133464 A1 WO 2008133464A1
Authority
WO
WIPO (PCT)
Prior art keywords
amino acids
biochip
concentrations
amino acid
quantitative analysis
Prior art date
Application number
PCT/KR2008/002395
Other languages
English (en)
Inventor
Jun Hyeong Cho
Dae-Yeon Cho
Hyun Gyu Park
Original Assignee
Labgenomics Co., Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Labgenomics Co., Ltd filed Critical Labgenomics Co., Ltd
Priority to CN200880021790A priority Critical patent/CN101688232A/zh
Publication of WO2008133464A1 publication Critical patent/WO2008133464A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms

Definitions

  • the present invention relates to a biochip for the quantitative analysis of amino acids and a method for analyzing amino acids using the same, and more particularly to a biochip for the quantitative analysis of amino acids, in which a plurality of E. coli mutants auxotrophic for different amino acids, the growth of which increases in proportion to the concentrations of specific amino acids, are immobilized on a flat substrate, as well as a method for analyzing the concentrations of amino acids using the biochip.
  • Amino acids are the basic structural building units of proteins, and examples thereof include 20 kinds of amino acids, including glycine, alanine, valine, leucine, isoleucine, threonine, serine, cysteine, methionine, aspartate, asparagine, glutamate, tyrosine, lysine, arginine, histidine, phenylalanine, glutamine, tryptophan and proline. These amino acids are classified into two groups: essential amino acids, which are not synthesized in vivo and must be supplied in the food, and nonessential amino acids. Such amino acids are important in human metabolic processes, and when the supply thereof is insufficient, various disorders will occur, thus leading to various diseases.
  • the concentration of amino acids in blood or urine indicates the nutritional status of the body, and thus the monitoring of the concentration of these amino acids in body fluids is important for verifying the therapeutic effects of diet or vitamin supplements.
  • the concentrations of phenylalanine, leucine and methionine are used as important markers in diagnosing congenital metabolic diseases in newborns.
  • Methods for analyzing amino acid concentration include thin-layer chromatography, electrophoresis, mass spectrometry, liquid chromatography and the like, and among them, ion-exchange liquid chromatography with post-column reactions, and with liquid column chromatography with pre-column reactions, are mainly used as commercial amino acid analyzers, because they are convenient to use and has high measurement accuracy (Slocum, R.H., Techniques in diagnostic human biochemical genetics: a laboratory manual, 87, 1991). Recently, tandem mass spectrometry (MS/MS), which performs high speed analysis and can handle a large amount of samples, has been recognized as important equipment for the diagnosis of congenital metabolic diseases in newborns.
  • MS/MS tandem mass spectrometry
  • microbiological assays which use microorganisms auxotrophic for specific amino acids, have been used for more than 60 years.
  • these methods have not been widely used, because they have problems in that they require long time for analysis is long and that analysis samples must be aseptically treated ⁇ Appl. Microbiol. Biotechnol., 76:91, 2007).
  • methods of analyzing amino acids using bioluminescent auxotrophic E. coli mutants have been reported (LB. Zabala et al., Appl. Microbiol. BiotechnoL, 62:268, 2003).
  • amino acids must be analyzed in solution using a microtiter plate without immobilizing an auxotrophic mutant on a substrate. For this reason, when various kinds of amino acids are analyzed, an E. coli mutant, an analysis sample and a solution such as buffer must be sequentially added to each well. Accordingly, when there are plural amino acids to be analyzed are plural, a large amount of a sample and a plurality of pippeting procedures are required, and thus it is unsuitable for use as commercial analysis kits.
  • the present inventors have made many efforts to develop a method for analyzing the concentrations of various kinds of amino acids in a sample in an accurate and simple manner.
  • the present inventors have developed a biochip, in which a plurality of E.
  • coli mutants auxotrophic for different amino acids are immobilized on a flat substrate, and have found that, when the proliferation of cells in a sample applied to the biochip is measured, the concentrations of various kinds of amino acids in the sample can be analyzed in an accurate and simple manner, thereby completing the present invention.
  • Another object of the present invention is to provide a method for analyzing the concentrations of amino acids in a sample using the biochip.
  • the present invention provides a biochip for the quantitative analysis of amino acids, in which a plurality of E. coli mutants auxotrophic for different amino acids are immobilized on a flat substrate.
  • the growth of the E. coli mutants preferably increases in proportion to the concentrations of the specific amino acids.
  • the E. coli mutants are preferably obtained using a method selected from the group consisting of mutagen treatment, homologous recombination and transposon insertion.
  • the immobilization of the E. coli mutant on the flat substrate is preferably performed using an immobilizing substance selected from the group consisting of agar, agarose, sodium alginate, sol-gel, chitosan, collagen, carrageenan, polyvinyl alcohol, polyurethane, polyethylene glycol and polyacrylamide.
  • an immobilizing substance selected from the group consisting of agar, agarose, sodium alginate, sol-gel, chitosan, collagen, carrageenan, polyvinyl alcohol, polyurethane, polyethylene glycol and polyacrylamide.
  • the amino acids are preferably selected from the group consisting of glycine, alanine, valine, leucine, isoleucine, threonine, serine, cysteine, methionine, aspartate, asparagine, glutamate, tyrosine, lysine, arginine, histidine, phenylalanine, glutamine, tryptophan, proline, taurine, sarcosine, homocysteine, betaine, citrulline, hydroxylproline and beta-alanine.
  • the flat substrate is preferably made of a material selected from the group consisting of plasties, glass, silicon, hydrogels, ceramics, metals and porous membranes.
  • the present invention provides a method for analyzing the concentrations of amino acids, the method comprises the steps of: (a) treating an amino acid-containing sample to said biochip and incubating the sample treated biochip; (b) adding a biomarker to the biochip treated with the amino acid- containing sample; and (c) analyzing the concentrations of amino acids in the sample by measuring the luminescence of the biomarker according to the proliferation of the mutant cells in the sample.
  • the biomarker is preferably selected from the group consisting of fluorescent dyes, luminescent dyes and color-developing dyes. Also, the biomarker is preferably a substance which can penetrate the cell membrane of the mutants.
  • the mutants preferably have a luminescent gene-containing recombinant vector introduced therein, and the luminescent gene is preferably a gene encoding luciferase.
  • the present invention provides a method for analyzing the concentrations of amino acids, the method comprises the steps of: (a) applying an amino acid-containing sample and a luminescent gene transcription inducer to a biochip, in which mutants having a luminescent gene-containing recombinant vector introduced into a plurality of E. coli mutants auxotrophic for different amino acids, are immobilized on a flat substrate, and incubating the treated biochip; and
  • the amino acid-containing sample is preferably selected from the group consisting of blood, food, injection solutions, nutrients and urine.
  • the biochip preferably has at least two kinds of amino acid auxotrophic strains immobilized thereon.
  • the biochip is preferably configured such that the amino acid auxotrophic strains immobilized at the respective locations grow at the same time.
  • FIG. 1 shows a process of measuring the concentrations of amino acids using the inventive biochip for the quantitative analysis of amino acids.
  • FIG. 2 illustrates photographs showing the results of luminescent analysis conducted to examine the selective specificities of the inventive biochip for 20 kinds of amino acids (glycine, alanine, valine, leucine, isoleucine, threonine, serine, cysteine, methionine, aspartate, asparagine, glutamate, tyrosine, lysine, arginine, histidine, phenylalanine, glutamine, tryptophan and proline).
  • amino acids glycine, alanine, valine, leucine, isoleucine, threonine, serine, cysteine, methionine, aspartate, asparagine, glutamate, tyrosine, lysine, arginine, histidine, phenylalanine, glutamine, tryptophan and proline.
  • FIG. 3 shows the growth of a methionine auxotrophic mutant according to the concentration of methionine, measured using a fluorescent dye syto9 and the inventive biochip for the quantitative analysis of six amino acids (methionine, isoleucine, leucine, threonine, arginine and lysine), which has a methionine auxotrophic mutant immobilized thereon.
  • FIG. 4 illustrates photographs showing the results of luminescent analysis conducted using the inventive biochip for the quantitative analysis of six amino acids in order to examine the growth of amino acid auxotrophic mutants according to the concentration of each amino acid.
  • FIG. 5 shows the change in luminescence according to the concentration of each amino acid, measured using the inventive biochip for the quantitative analysis of six amino acids.
  • FIG. 6 shows the change in luminescence according to the concentration of each amino acid, measured using the inventive biochip for the quantitative analysis of 20 amino acids (glycine, alanine, valine, leucine, isoleucine, threonine, serine, cysteine, methionine, aspartate, asparagine, glutamate, tyrosine, lysine, arginine, histidine, phenylalanine, glutamine, tryptophan and proline).
  • amino acids glycine, alanine, valine, leucine, isoleucine, threonine, serine, cysteine, methionine, aspartate, asparagine, glutamate, tyrosine, lysine, arginine, histidine, phenylalanine, glutamine, tryptophan and proline.
  • FIG. 7 shows the change in luminescence according to the concentration of each of four amino acids (isoleucine, lysine, arginine and tyrosine), measured through ATP analysis using the inventive biochip for the quantitative analysis of 20 amino acids.
  • FIG. 8 shows the change in luminescence according to the concentration of histidine in a human serum sample, measured using the inventive biochip for the quantitative analysis of 20 amino acids.
  • the present invention relates to a a biochip for the quantitative analysis of amino acids, in which a plurality of E. coli mutants auxotrophic for different amino acids are immobilized on a flat substrate.
  • Amino acid auxotrophic strains according to the present invention can be prepared by any one of the following three methods.
  • the methods include a method of treating autotrophic microorganisms, having the ability to produce amino acids, with a chemical substance (e.g., NTG (N-methyl-N-nitro-N-nitrosoguanidine)), a method of obtaining amino acid auxotrophic mutants by inducing mutations using UV light, and a method of inactivating the ability of microorganisms to synthesize amino acids using DNA recombination technology or a transposon.
  • a chemical substance e.g., NTG (N-methyl-N-nitro-N-nitrosoguanidine)
  • the method that uses DNA recombination technology can be performed by introducing a nucleotide sequence or vector, having homology with a specific gene associated with the growth of microorganisms, into target microorganisms to induce homologous recombination.
  • the introduced nucleotide sequence or vector contains a selection marker capable of selecting mutated microorganisms, which allows mutants to be easily selected.
  • amino acid auxotrophic mutants were prepared by inducing mutations using a transposon.
  • auxotrophic mutants for different amino acids were prepared by introducing a selection marker-containing transposon into an E. coli ATCC 11105 strain to randomly induce mutations in the chromosome, and then selecting strains, the growth of which was inhibited in an amino acid-deficient environment.
  • the introduction of a transposon into the host cell may be performed by, but is not limited to, e.g., transformation or electroporation.
  • a competent strain was made by a suitable method, such that external substances, such as DNA or transposons, would be easily introduced into the strain. Then, the microorganism was mixed with a transposon, the transposon was inserted into the microbial cell using a conventional technique such as an electric pulse method, and then the cell was cultured. Then, transformed strains were screened by an antibiotic-resistant gene contained in the transposon. Alternatively, the cell was cultured in an antibiotic-containing plate medium, and antibiotic-resistant strains, in which gene inactivation occurred due to the insertion of the transposon, were selected. Among the selected antibiotic-resistant strains, strains, which did not grow in minimal medium, but grew in a medium containing each of amino acids, were selected, and auxotrophic mutants for the corresponding amino acids were isolated.
  • the present invention relates to a method for analyzing the concentrations of amino acids using the biochip.
  • the method for analyzing the concentrations of amino acids according to the present invention comprises the steps of: (a) applying an amino acid-containing sample to said biochip and incubating the sample treated biochip; (b) adding a biomarker to the biochip treated with the amino acid-containing sample; and (c) analyzing the concentrations of amino acids in the sample by measuring the luminescence of the biomarker according to the proliferation of the mutant cells in the sample.
  • the concentrations of amino acids in an unknown sample can be quantitatively measured by adding an amino acid- containing M9 minimal medium to each microplate of the biochip, incubating the biochip at 37 ° C for 4 hours, and then examining the growth of the amino acid auxotrophic mutants.
  • any sample may be used, as long as it contains amino acids.
  • the sample may include, but are not limited to, body fluids, such as blood, urine or serum, and food.
  • the method of examining the growth of the amino acid auxotrophic mutants may be performed using various methods, such as fluorescence staining methods or enzyme immunoassays.
  • the concentrations of amino acids in a sample may be measured by adding an amino acid-containing sample to the biochip for amino acid analysis, in which the above-prepared E. coli mutants auxotrophic for different amino acids are immobilized on a flat substrate, culturing the cells of the mutants, staining the cells with a fluorescent substance (e.g., syto9 (Invitrogen, USA)), which can penetrate the cell membrane of the mutants, at room temperature for 1 hour, and measuring the luminescence of the fluorescent substance according to the proliferation of the cells using a fluorimeter.
  • a fluorescent substance e.g., syto9 (Invitrogen, USA)
  • amino acid auxotrophic mutants in order to quantitatively analyze the growth of the amino acid auxotophic mutants according to the amino acid concentrations in proportion to the expression of a recombinant luciferase gene, amino acid auxotrophic mutants, into which a recombinant plasmid pTAC-luc containing a gene encoding luciferase is introduced, were prepared.
  • the amino acid auxotrophic mutants prepared according to the present invention are strains derived from E. coli ATCC 11105 and are auxotrophic for arginine, methionine, histidine, valine, isoleucine, leucine, phenylalanine, alanine, threonine, cysteine, glutamate, glutamine, aspartate, asparagine, tryptophan, tyrosine, serine, proline, glycine and lysine.
  • the above-prepared amino acid auxotrophic mutants were immobilized on a flat substrate. In a preferred embodiment, the mutants were mixed with agar and solidified.
  • agar in order to immobilize the amino acid auxotrophic mutants, 0.7% agar was completely dissolved by heating at 100°C , and then was cooled slowly to about 50 ° C . Then, the cooled agar was mixed with each of the amino acid auxotrophic mutants, and 0.1 ml of each of the mixtures was dispensed into a microplate and left to stand at room temperature, such that the substrate could be sufficiently solidified.
  • the substrate prepared by the immobilization of the auxotrophic mutants can be changed depending on temperature, and the number of cells immobilized on the substrate may vary depending on temperature.
  • the concentrations of amino acids can be measured by measuring the proliferation of cells through the luminescence of the luminescent gene.
  • the present invention relates to a method for analyzing the concentrations of amino acids, the method comprises the steps of: (a) applying an amino acid-containing sample and a luminescent gene transcription inducer to a biochip, in which mutants having a luminescent gene-containing recombinant vector introduced into a plurality of E. coli mutants auxotrophic for different amino acids, are immobilized on a flat substrate, and incubating the treated biochip; and (b) measuring the expression of the luminescent gene or the amount of ATP according to the proliferation of the mutant cells in the sample, thus analyzing the concentrations of amino acids in the sample.
  • a recombinant vector containing a luminescent gene was introduced into a plurality of E. coli mutants auxotrophic for different amino acids, and the resulting mutants were immobilized on a flat substrate to prepare a biochip. Then, the quantitative analysis of amino acid concentrations was attempted by measuring the expression of the luminescent gene using the biochip or by detecting a substance showing luminescence by binding to ATP, the concentration of which increased with the growth of cells.
  • E. coli strain (ATCC 11105) was inoculated into 3 ml of LB medium (10 g/L trypton, 5 g/L yeast extract and 10 g/L NaCl) and cultured overnight. Then, the strain cells were collected by centrifugation and washed twice with 10% glycerol aqueous solution. Then, the cells were centrifuged again and suspended in 10% glycerol aqueous solution, thus preparing a competent E. coli strain such that a substance, such as DNA or transposons, would be easily introduced there into.
  • LB medium 10 g/L trypton, 5 g/L yeast extract and 10 g/L NaCl
  • the resulting strain was cultured at 37 ° C for 1 hour. Then, the cultured strain was diluted with LB medium at a ratio of 1 : 10 and plated on a selection medium containing 50 mg/L kanamycin. Then, the strain was cultured overnight at 37 ° C , thus obtaining a transformed strain.
  • the transformed strain was plated on a selection medium, containing 50 mg/L kanamycin, and M9 minimal medium (Table 1) containing 1 nM cyanocobalamin, and was cultured overnight at 37 " C .
  • amino acid auxotrophic mutants were performed by selecting strains, which grew on an antibiotic-containing agar plate, but did not grow in minimal medium, and isolating an amino acid auxotrophic mutant, in which a specific gene associated with microbial growth was inactivated by an antibiotic- resistant gene.
  • the primarily selected auxotrophic mutant was inoculated into 3 ml of a kanamycin-containing LB medium and was then cultured overnight. Then, the culture medium was centrifuged to collect a strain, and the remaining LB medium component was removed using minimal medium. Then, the strain was inoculated in a cell culture tube, containing 0.1 ml of M9 minimal medium and 50 ⁇ M of each amino acid, at a ratio of 1 :500, and then was cultured at 37 0 C overnight. Then, auxotrophic mutants for the corresponding amino acids, which grew in the medium containing each amino acid, were selected.
  • amino acid auxotrophic mutants In order to quantitatively analyze the growth of the amino acid auxotrophic mutants according to the concentration of amino acids through the expression of the recombinant luminescent gene, amino acid auxotrophic mutants, into which a recombinant plasmid pTAC-luc, containing a luciferase-encoding gene is introduced, were prepared.
  • a recombinant plasmid pTAC-luc the Tl lac of a pETDuet-1 plasmid (Novagen, San Diego, CA, USA) was substituted with a tac promoter.
  • a Photinus pyralis (firefly)-derived luciferase-encoding gene was amplified by PCR using a pGL3 -Basic plasmid (Promega, WI, USA) as a template with oligoprimers of SEQ ID NO: 1 (JVcoI-luc-F) and SEQ ID NO: 2 (JECORI-IUC-R).
  • SEQ ID NO: 1 5'-CATGCCATGGAAGACGCCAAAAACATAAAGAAAGGC-S'
  • SEQ ID NO: 2 5'-CGGAATTCCTAGAATTACACGGCGATCTTTCCGC-S'
  • the amplified gene was digested with restriction enzymes Nc ⁇ l and EcoRI, and then ligated into a Ptac plasmid treated with the same restriction enzymes, thus constructing a recombinant plasmid pTAC-luc.
  • the constructed recombinant plasmid pTAC-luc was introduced into each of the amino acid auxotrophic mutants, prepared in Example I 5 using an electric pulse method, thus preparing amino acid auxotrophic mutants containing the recombinant luminescent gene.
  • each culture broth was centrifuged to collect the mutants, which were then suspended in M9 minimal medium and centrifuged again. The process of suspension and centrifugation was repeated three times, .thus removing the remaining LB medium component.
  • Each of the resulting amino acid auxotrophic mutants was suspended in M9 minimal medium, and about 1 x 10 6 cells of each of the mutants were taken and mixed with an agar solution.
  • the agar solution was prepared by sterilizing 0.7% agar solution at high pressure and high temperature, and then cooling the sterilized solution to about 50 ° C .
  • 0.1 ml of each of the mixtures was dispensed into two rows of a 96-well microplate arranged in 8 columns by 12 rows, and was then left to stand at room temperature for 30 minutes, such that the substrate could be solidified, thus preparing a biochip for the quantitative analysis of six amino acids.
  • Each of the 20 amino acid auxotrophic mutants (auxotrophic for arginine, methionine, histidine, valine, isoleucine, leucine, phenylalanine, alanine, threonine, cysteine, glutamate, glutamine, aspartate, asparagine, tryptophan, tyrosine, serine, proline, glycine and lysine), prepared in Example 2, which contain the recombinant luciferase gene, was mixed with the agar solution according to the above-described method.
  • the biochip having 20 spots was treated with 10 ⁇ M of each of amino acid solutions, and after 3 hours, the luminescence of the luciferase gene was measured. As a result, it could be observed that the luminescence of the luciderase gene was detected only at the spot corresponding to each of the supplied amino acids (FIG. 2).
  • Example 3-1 To the biochip for the quantitative analysis of 6 amino acids, prepared in Example 3-1, which has a methionine auxotrophic mutant immobilized thereon, a minimal medium containing 3 ⁇ M methionine was added, and then the biochip was incubated at 37 °C for 4 hours. Then, a fluorescent dye syto9 (Invitrogen, USA) capable of penetrating the cell membrane of the mutants was added to sterilized water to each of final concentrations of 0.2 mM and 2 mM, and 0.1 ml of each of the solutions was added to the biochip having the methionine auxotrophic mutant immobilized thereon, and then was left to stand at room temperature for 1 hour.
  • a fluorescent dye syto9 Invitrogen, USA
  • the change in the luminescence of the luciferase gene was measured at 488/525 using a luminometer.
  • the concentration of the amino acid was proportional to the luminescence which increased along with the proliferation of cells.
  • Example 3-1 Into each well of the biochip for the quantitative analysis of 6 amino acids, prepared in Example 3-1, a solution, containing 0.1 ml of M9 minimal medium, 1 nM cyanocobalamin and each of amino acids having varying concentrations as shown in Table 3, was dispensed. As a control group, only 0.1 ml of M9 minimal medium was dispensed into the first column of the biochip. The biochip was cultured at 37 °C for 4 hours, and then 0.1 ml of a BacTiter-GloTM Microbial Cell Viability Assay Kit (Promega, USA) was added to each well of the biochip and allowed to react at room temperature for 10 minutes. Then, the amount of ATP generated from the mutants was measured using a laminometer.
  • a solution containing 0.1 ml of M9 minimal medium, 1 nM cyanocobalamin and each of amino acids having varying concentrations as shown in Table 3, was dispensed.
  • As a control group only
  • the concentrations of the amino acids were proportional to the amount of ATP which increased along with the proliferation of cells.
  • the recombinant plasmid pTAC-luc prepared in Example 2, shows luminescence, when the substrate D-luciferin and IPTG inducing transcription of a luciferase- encoding gene, are supplied.
  • the concentration of each of the amino acids was proportional to the expression level of luciferase, which increased along with the proliferation of cells.
  • Example 3-2 To the biochip for the quantitative analysis of 20 amino acids, prepared in Example 3-2, a BacTiter-GloTM Microbial Cell Viability Assay Kit (Promega, USA) was added, and the change in luminescence according to the amount of ATP was measured.
  • a solution containing 0.1 ml of M9 minimal medium, 1 nM cyanocobalamin and four different amino acids (isoleucine, lysine, arginine and tyrosine) at varying concentrations as shown in Table 4, was dispensed into the biochip prepared in Example 3-2.
  • the biochip was incubated at 37 °C for 3 hours, and then 0.1 ml of a BacTiter-GloTM Microbial Cell Viability Assay Kit (Promega, USA) was added to each well of the biochip and allowed to react at room temperature for 10 minutes. Then, the amount of ATP generated from each of the mutants was measured using a luminometer. Because the amount of ATP generated was proportional to the number of cells, the use of the measurement values allowed the concentrations of the amino acids in the sample to be analyzed.
  • the concentrations of the amino acids were proportional to the amount of ATP, which increased along with the proliferation of cells.
  • the concentrations of amino acids in human serum were measured through the change in luminescence.
  • the concentrations of amino acids in the serum were measured using the analysis method described in Example 5-3.
  • the luminescence of the recombinant luciferase gene was increased in proportion to the concentrations of amino acids in the serum.
  • the concentration of histidine in human serum was measured through the change in luminescence.
  • M9 minimal medium containing each of 0, 6, 12 and 18 ⁇ M histidine was added to the biochip.
  • the biochip having the serum added thereto was incubated at 37 ° C for 3 hours, and then the concentration of the amino acid in the serum was measured using the analysis method described in Example 5-3.
  • the measurement value was 15830 (RLU), and the concentration of histidine in human serum, calculated based on the standard curve, was about 10.5 ⁇ M (FIG. 8).
  • the present invention provides a biochip for the quantitative analysis of amino acids, in which E. coli mutants auxotrophic for different amino acids, the growth of which increases in proportion to the concentrations of specific amino acids, are immobilized on a flat substrate, and a method for analyzing amino acids using the biochip.
  • the concentrations of amino acids in a sample can be simply analyzed only by adding the sample and measuring an increase in the number of cells.
  • the analysis method has an economical effect of greatly reducing the costs, required for amino acid analysis, because it does not require expensive equipment or reagents.
  • the inventive biochip for the quantitative analysis of amino acids is used, various kinds of amino acids can be analyzed in an accurate and simple manner.
  • the biochip according to the present invention allows miniaturization of analysis kits, and thus it can be applied in an analysis process requiring small samples or an analysis process requiring a large amount of analytes.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

L'invention concerne une biopuce pour l'analyse quantitative d'acides aminés et un procédé pour analyser des acides aminés au moyen de ladite biopuce. L'invention concerne plus particulièrement une biopuce pour l'analyse quantitative d'acides aminés, dans lesquels une pluralité de mutants auxotrophes d' E. coli provenant de différents acides aminés dont la croissance augmente proportionnellement aux concentrations d'acides aminés spécifiques, sont immobilisés sur un substrat plat; et un procédé pour l'analyse des concentrations d'acides aminés au moyen de la biopuce. L'utilisation de la biopuce précitée permet d'analyser les concentrations de différents types d'acides aminés de manière précise et simple, et fournit en outre un effet économique de réduction considérable des coûts d'analyse d'acides aminés du fait que cette dernière ne requiert pas d'équipements ou de réactifs d'analyse chers.
PCT/KR2008/002395 2007-04-27 2008-04-28 Biopuce pour quantifier des acides aminés et procédé pour analyser des acides aminés au moyen de ladite biopuce WO2008133464A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN200880021790A CN101688232A (zh) 2007-04-27 2008-04-28 定量氨基酸的生物芯片及使用该芯片分析氨基酸的方法

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2007-0041059 2007-04-27
KR20070041059 2007-04-27

Publications (1)

Publication Number Publication Date
WO2008133464A1 true WO2008133464A1 (fr) 2008-11-06

Family

ID=39925861

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2008/002395 WO2008133464A1 (fr) 2007-04-27 2008-04-28 Biopuce pour quantifier des acides aminés et procédé pour analyser des acides aminés au moyen de ladite biopuce

Country Status (2)

Country Link
CN (1) CN101688232A (fr)
WO (1) WO2008133464A1 (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101211095B1 (ko) * 2010-05-20 2012-12-11 주식회사 랩 지노믹스 호모시스테인 정량 분석용 미생물 및 그의 용도
US20130095497A1 (en) * 2010-05-20 2013-04-18 Labgenomics Co., Ltd. Microorganism for quantifying homocysteine, and use thereof
KR102047827B1 (ko) * 2019-05-28 2019-11-22 한국생산기술연구원 아미노산 정량 분석 바이오칩, 이를 포함하는 아미노산 정량 분석 키트 및 이를 이용한 아미노산 정량 분석 방법

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20200137135A (ko) 2019-05-29 2020-12-09 한국생산기술연구원 영양요구성 미생물을 이용한 아미노산 검출 센서
CN113881616B (zh) * 2021-10-12 2022-08-02 江南大学 一种细菌纤维素基生物传感器及其应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070031913A1 (en) * 2004-02-06 2007-02-08 Ajinomoto Co., Inc. Amino-acid biosensor, fischer-ratio biosensor and health information management system

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070031913A1 (en) * 2004-02-06 2007-02-08 Ajinomoto Co., Inc. Amino-acid biosensor, fischer-ratio biosensor and health information management system

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
ATSUSHI SEKI ET AL.: "Microbial assay for tryptophan using silicon-based transducer", SENSORS AND ACTUATORS B, vol. 94, no. 3, October 2003 (2003-10-01), pages 253 - 256, XP004442283 *
LI X. AND RICKE S.C.: "Generation of an Escherichia coli lysA targeted deletion mutant by double cross-over recognition for potential use in a bacterial growth-based lysine assay", LETTERS IN APPLIED MICROBIOLOGY, vol. 37, no. 6, December 2003 (2003-12-01), pages 458 - 462, XP055005294, DOI: doi:10.1046/j.1472-765X.2003.01425.x *
ZABALA DIAZ I.B. AND RICKE S.C.: "Quantitative detection of crystalline lysine supplementation in poultry feeds using a rapid bacterial bioluminescence assay", APPLIED MICROBIAL BIOTECHNOLOGY, vol. 62, no. 2-3, August 2003 (2003-08-01), pages 268 - 273 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101211095B1 (ko) * 2010-05-20 2012-12-11 주식회사 랩 지노믹스 호모시스테인 정량 분석용 미생물 및 그의 용도
US20130095497A1 (en) * 2010-05-20 2013-04-18 Labgenomics Co., Ltd. Microorganism for quantifying homocysteine, and use thereof
US8759021B2 (en) * 2010-05-20 2014-06-24 Labgenomics Co., Ltd. Microorganism for quantifying homocysteine, and use thereof
KR102047827B1 (ko) * 2019-05-28 2019-11-22 한국생산기술연구원 아미노산 정량 분석 바이오칩, 이를 포함하는 아미노산 정량 분석 키트 및 이를 이용한 아미노산 정량 분석 방법

Also Published As

Publication number Publication date
CN101688232A (zh) 2010-03-31

Similar Documents

Publication Publication Date Title
WO1999066066A1 (fr) Analyse comparative de phenotypes
AU2017393714B2 (en) Genotoxic substance detection vector and detection method thereof
WO2008133464A1 (fr) Biopuce pour quantifier des acides aminés et procédé pour analyser des acides aminés au moyen de ladite biopuce
US10501815B2 (en) Glucose sensors and methods of use thereof
IL294764A (en) Activity-specific cell enrichment
EP3108007B1 (fr) Procédé de détection d'un micro-organisme dans un échantillon par un procédé de détection fondé sur la fluorescence à l'aide de somamers
CN109207634A (zh) 海州常山干旱胁迫下荧光定量内参基因及其专用引物和应用
CN115160416A (zh) 一种感应潜艇金属离子Cd(II)的AraC突变体及其构建的探潜微生物传感器和应用
CN112662732A (zh) 一种泛酸合成酶突变体的高通量快速筛选方法
US20070099259A1 (en) Electrochemical assay for the identification of microorganisms
CN110004074B (zh) 一种利用silac标记耻垢分枝杆菌蛋白质的方法及其专用培养基
KR101769789B1 (ko) Nad(h) 정량용 조성물, 정량 방법 및 이의 용도
US7947440B2 (en) Method for determining the specific growth rate of a distinct cell population within a non-homogeneous system
KR102047827B1 (ko) 아미노산 정량 분석 바이오칩, 이를 포함하는 아미노산 정량 분석 키트 및 이를 이용한 아미노산 정량 분석 방법
CN109576298A (zh) 利用细胞透性化处理提高非天然氨基酸引入蛋白效率的方法
AU766252B2 (en) Method for separating and characterising functions potentially present in a biological sample containing nucleic acids
AU2003226729A1 (en) Method for the identification of microorganisms by means of in situ hybridization and flow cytometry
CN114164296B (zh) 一种用于检测寡雄腐霉菌的引物探针组合物、试剂盒及应用和检测方法
WO2017002080A1 (fr) Système de détection de toxines liées à une intoxication paralysante par des mollusques à base de micro-organismes génétiquement modifiés
CN110527691B (zh) 一种高效制备O-GlcNAc修饰蛋白的大肠杆菌表达体系
JP5406253B2 (ja) タンパク質発現に基づくアミノ酸バイオアッセイ法
JP2001169778A (ja) 迅速細菌遺伝子検査法及びキット
CN117070431A (zh) 一种基于生物发光的糖肽类抗生素全细胞生物传感器及其制备方法与应用
Mbeunkui The effects of low nitrate levels on the freshwater cyanobacterium Synechocystis sp. strain PCC 6803: construction of a bioreporter assay and molecular characterization by transcriptome and proteome analysis
RU2525934C1 (ru) Способ видовой дифференциации жизнеспособных родококков, иммобилизованных в гелевом носителе

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200880021790.4

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08753204

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08753204

Country of ref document: EP

Kind code of ref document: A1